Literature DB >> 11873711

The case of the missing data: methods of dealing with dropouts and other research vagaries.

David L Streiner1.   

Abstract

Missing data are common in most studies, especially when subjects are followed over time. This can jeopardize the validity of a study because of reduced power to detect differences, and especially because subjects who are lost to follow-up rarely represent the group as a whole. There are several approaches to handling missing data, but some may result in biased estimates of the treatment effect, and others may overestimate the significance of the statistical tests. When cross-sectional data (for example, demographic and background information and a single outcome measurement time) are missing, replacement with the group mean leads to an underestimate of the standard deviation (SD) and inflation of the Type I error rate. Using regression estimates, especially with error built into the imputed value, lessens but does not eliminate this problem. Multiple imputation preserves the estimates of both the mean and the SD, even when a significant proportion of the data are missing. With longitudinal studies, the last observation carried forward (LOCF) approach preserves the sample size, but may make unwarranted assumptions about the missing data, resulting in either underestimating or overestimating the treatment effects. Growth curve analysis makes maximal use of the existing data and makes fewer assumptions.

Entities:  

Mesh:

Year:  2002        PMID: 11873711

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  45 in total

Review 1.  Is longer-term psychodynamic psychotherapy more effective than shorter-term therapies? Review and critique of the evidence.

Authors:  Sunil S Bhar; Brett D Thombs; Monica Pignotti; Marielle Bassel; Lisa Jewett; James C Coyne; Aaron T Beck
Journal:  Psychother Psychosom       Date:  2010-04-29       Impact factor: 17.659

2.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

Review 3.  Risperidone alone or in combination for acute mania.

Authors:  J M Rendell; H J Gijsman; M S Bauer; G M Goodwin; G R Geddes
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

4.  Does analysis using "last observation carried forward" introduce bias in dementia research?

Authors:  Frank J Molnar; Brian Hutton; Dean Fergusson
Journal:  CMAJ       Date:  2008-10-07       Impact factor: 8.262

5.  Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression.

Authors:  Jason A Gandelman; Hakmook Kang; Ashleigh Antal; Kimberly Albert; Brian D Boyd; Alexander C Conley; Paul Newhouse; Warren D Taylor
Journal:  J Clin Psychiatry       Date:  2018-08-28       Impact factor: 4.384

6.  Literacy education as treatment for depression in patients with limited literacy and depression: a randomized controlled trial.

Authors:  Barry D Weiss; Laurie Francis; Janet H Senf; Kim Heist; Rie Hargraves
Journal:  J Gen Intern Med       Date:  2006-08       Impact factor: 5.128

7.  The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer survivors: a randomized controlled trial.

Authors:  Kerri M Winters-Stone; Jessica Dobek; Jill A Bennett; Lillian M Nail; Michael C Leo; Anna Schwartz
Journal:  J Cancer Surviv       Date:  2011-12-23       Impact factor: 4.442

Review 8.  Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia.

Authors:  David B Hogan; Peter Bailey; Sandra Black; Anne Carswell; Howard Chertkow; Barry Clarke; Carole Cohen; John D Fisk; Dorothy Forbes; Malcolm Man-Son-Hing; Krista Lanctôt; Debra Morgan; Lilian Thorpe
Journal:  CMAJ       Date:  2008-11-04       Impact factor: 8.262

Review 9.  The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study.

Authors:  Eveline Nüesch; Sven Trelle; Stephan Reichenbach; Anne W S Rutjes; Elizabeth Bürgi; Martin Scherer; Douglas G Altman; Peter Jüni
Journal:  BMJ       Date:  2009-09-07

10.  Missing outcomes in randomized trials: addressing the dilemma.

Authors:  Douglas G Altman
Journal:  Open Med       Date:  2009-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.